Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lazarus

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
International Archives of Allergy and Immunology|April 18, 2001
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthmaE Israel, J M Drazen, S B Liggett, et al.
Microbiome|June 11, 2018
Bacterial biogeography of adult airways in atopic asthmaJuliana Durack, Yvonne J Huang, Snehal Nariya, et al.
COPD|February 9, 2011
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationPrescott G Woodruff, Richard K Albert, William C Bailey, et al.
Lancet (London, England)|October 27, 2004
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialElliot Israel, Vernon M Chinchilli, Jean G Ford, et al.
The New England Journal of Medicine|August 26, 2011
Azithromycin for prevention of exacerbations of COPDRichard K Albert, John Connett, William C Bailey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseMark T Dransfield, Sarah Harnden, Robert L Burton, et al.
The New England Journal of Medicine|April 15, 2005
Daily versus as-needed corticosteroids for mild persistent asthmaHomer A Boushey, Christine A Sorkness, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2019
Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trialsNicole L Grossman, Victor E Ortega, Tonya S King, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2009
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceHelen K Reddel, D Robin Taylor, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2012
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapyLoren C Denlinger, David M Manthei, Max A Seibold, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
International Archives of Allergy and Immunology|April 18, 2001
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthmaE Israel, J M Drazen, S B Liggett, et al.
Microbiome|June 11, 2018
Bacterial biogeography of adult airways in atopic asthmaJuliana Durack, Yvonne J Huang, Snehal Nariya, et al.
COPD|February 9, 2011
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationPrescott G Woodruff, Richard K Albert, William C Bailey, et al.
Lancet (London, England)|October 27, 2004
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialElliot Israel, Vernon M Chinchilli, Jean G Ford, et al.
The New England Journal of Medicine|August 26, 2011
Azithromycin for prevention of exacerbations of COPDRichard K Albert, John Connett, William C Bailey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary diseaseMark T Dransfield, Sarah Harnden, Robert L Burton, et al.
The New England Journal of Medicine|April 15, 2005
Daily versus as-needed corticosteroids for mild persistent asthmaHomer A Boushey, Christine A Sorkness, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2019
Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trialsNicole L Grossman, Victor E Ortega, Tonya S King, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2009
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceHelen K Reddel, D Robin Taylor, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2012
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapyLoren C Denlinger, David M Manthei, Max A Seibold, et al.
Pageof 21